Researchers at the U-M Health Rogel Cancer Center have not only uncovered a key reason why a typically normal protein goes awry and fuels cancer but also a potential new way to therapeutically target prostate cancer. Abhijit Parolia, Ph.D., first author of the study and assistant professor of pathology at Michigan Medicine, shares key findings from the team’s research.
